1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Recurrent Mucosal Melanoma: new trials by email Literature Review of Recurrent Mucosal Melanoma trials Research Report on Recurrent Mucosal Melanoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery Biospecimen Collection, Bone Scan, Cabozantinib S-malate - Anal Melanoma, Bladder Melanoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 101 | 2022-08-11 | 2026-08-04 |
Magnetic Resonance Spectroscopy (1) · Nivolumab (1) · Specimen Handling (1) · cabozantinib (1)
National Cancer Institute (NCI) (1)
Canada (1) · United States (1)
U10CA180821 (1)